Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial

類似資料

• Interleukin-1 beta inhibition with canakinumab and reducing lung cancer—subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
  著者:: Crossman, David, 等
  出版事項: (2018)
• Role of Anti-inflammatory Interventions in Coronary Artery Disease: Understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
  著者:: Lorenzatti, Alberto, 等
  出版事項: (2018)
• Canakinumab and cardiovascular outcomes: results of the CANTOS trial
  著者:: Shah, Syed Raza, 等
  出版事項: (2018)
• Canakinumab and cardiovascular outcomes: results of the CANTOS trial
  著者:: Syed Raza Shah, 等
  出版事項: (2018-01-01)
• Novel Anti-Atherosclerotic Therapies
  著者:: Libby, Peter, 等
  出版事項: (2019)